Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obesity and hypertension.

L E Ramsay1

  • 1University Department of Therapeutics, Royal Hallamshire Hospital, Sheffield, UK.

Nephron
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Weight reduction significantly lowers blood pressure and associated cardiovascular risks in overweight hypertensive individuals. This approach corrects multiple health issues, often reducing the need for medication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canrenone--the principal active metabolite of spironolactone?

British journal of clinical pharmacology·2012
Same author

No evidence that panic attacks are associated with the white coat effect in hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2003
Same author

Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis.

Clinical radiology·2002
Same author

First-line treatment for hypertension.

European heart journal·2002
Same author

Statins for primary prevention: at what coronary risk is safety assured?

British journal of clinical pharmacology·2001
Same author

Dysfunctional breathing and asthma. Panic disorder needs to be considered.

BMJ (Clinical research ed.)·2001

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Obesity Research

Background:

  • Hypertension frequently coexists with obesity, leading to increased cardiovascular disease risks.
  • Overweight individuals with hypertension often present with hypercholesterolemia, impaired glucose tolerance, and left ventricular hypertrophy.
  • Antihypertensive drug therapy alone does not address these comorbid conditions.

Purpose of the Study:

  • To evaluate the impact of weight reduction as a primary management strategy for hypertension in overweight individuals.
  • To assess the effect of weight reduction on associated metabolic and cardiovascular risk factors.
  • To compare the efficacy of weight reduction versus solely pharmacological blood pressure control.

Main Methods:

  • Observational analysis of hypertensive subjects with overweight status.

Related Experiment Videos

  • Assessment of blood pressure changes following weight reduction interventions.
  • Monitoring of associated risk factors including lipid profiles, glucose tolerance, and cardiac structure.

    • Main Results:

    • Substantial and sustained reduction in blood pressure observed with weight loss.
    • Significant improvement or correction of hypercholesterolemia, impaired glucose tolerance, and left ventricular hypertrophy.
    • Reduced or eliminated need for antihypertensive drug treatment in many cases.

    Conclusions:

    • Weight reduction is a highly effective and rational primary management strategy for hypertension in overweight individuals.
    • Addressing obesity corrects multiple cardiovascular disease risk factors concurrently with lowering blood pressure.
    • Lifestyle intervention through weight management offers a superior approach to managing complex cardiovascular risk profiles.